These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16304179)

  • 1. In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery.
    Hutschala D; Skhirtladze K; Zuckermann A; Wisser W; Jaksch P; Mayer-Helm BX; Burgmann H; Wolner E; Müller M; Tschernko EM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5107-11. PubMed ID: 16304179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of perioperative atelectasis on antibiotic penetration into lung tissue: an in vivo microdialysis study.
    Hutschala D; Kinstner C; Skhirtladze K; Mayer-Helm BX; Zeitlinger M; Wisser W; Müller M; Tschernko E
    Intensive Care Med; 2008 Oct; 34(10):1827-34. PubMed ID: 18478200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study testing whether concentrations of levofloxacin in interstitial space fluid of soft tissues may serve as a surrogate for predicting its pharmacokinetics in lung.
    Zeitlinger MA; Traunmüller F; Abrahim A; Müller MR; Erdogan Z; Müller M; Joukhadar C
    Int J Antimicrob Agents; 2007 Jan; 29(1):44-50. PubMed ID: 17189094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis.
    Zeitlinger MA; Dehghanyar P; Mayer BX; Schenk BS; Neckel U; Heinz G; Georgopoulos A; Müller M; Joukhadar C
    Antimicrob Agents Chemother; 2003 Nov; 47(11):3548-53. PubMed ID: 14576116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
    Conte JE; Golden JA; McIver M; Zurlinden E
    Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue pharmacokinetics of levofloxacin in human soft tissue infections.
    Bellmann R; Kuchling G; Dehghanyar P; Zeitlinger M; Minar E; Mayer BX; Müller M; Joukhadar C
    Br J Clin Pharmacol; 2004 May; 57(5):563-8. PubMed ID: 15089808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
    Conte JE; Golden JA; McIver M; Little E; Zurlinden E
    Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500 mg, 750 mg and 1000 mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP).
    Noreddin AM; Marras TK; Sanders K; Chan CK; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2004 Nov; 24(5):479-84. PubMed ID: 15519481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacin exposure in a rabbit tissue cage model.
    Xuan D; Zhong M; Mattoes H; Bui KQ; McNabb J; Nicolau DP; Quintiliani R; Nightingale CH
    Antimicrob Agents Chemother; 2001 Mar; 45(3):794-9. PubMed ID: 11181363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.
    Drusano GL; Preston SL; Fowler C; Corrado M; Weisinger B; Kahn J
    J Infect Dis; 2004 May; 189(9):1590-7. PubMed ID: 15116294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    Tomaselli F; Dittrich P; Maier A; Woltsche M; Matzi V; Pinter J; Nuhsbaumer S; Pinter H; Smolle J; Smolle-Jüttner FM
    Br J Clin Pharmacol; 2003 Jun; 55(6):620-4. PubMed ID: 12814459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis.
    Tomaselli F; Maier A; Matzi V; Smolle-Jüttner FM; Dittrich P
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2228-32. PubMed ID: 15155226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.
    Lee LJ; Sha X; Gotfried MH; Howard JR; Dix RK; Fish DN
    Pharmacotherapy; 1998; 18(1):35-41. PubMed ID: 9469679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gatifloxacin and levofloxacin administered at various dosing regimens to hospitalised patients with community-acquired pneumonia: pharmacodynamic target attainment study using North American surveillance data for Streptococcus pneumoniae.
    Noreddin AM; Hoban DJ; Zhanel GG
    Int J Antimicrob Agents; 2005 Aug; 26(2):120-5. PubMed ID: 16046101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.
    Firsov AA; Vostrov SN; Lubenko IY; Arzamastsev AP; Portnoy YA; Zinner SH
    J Antimicrob Chemother; 2004 Jul; 54(1):178-86. PubMed ID: 15190041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM; Kinzig-Schippers M; Tischmeyer U; Wagenlehner C; Sörgel F; Dalhoff A; Naber KG
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo microdialysis to measure antibiotic penetration into soft tissue during cardiac surgery.
    Hutschala D; Skhirtladze K; Kinstner C; Mayer-Helm B; Müller M; Wolner E; Tschernko EM
    Ann Thorac Surg; 2007 Nov; 84(5):1605-10. PubMed ID: 17954069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion of levofloxacin into bone and synovial tissues.
    Rimmelé T; Boselli E; Breilh D; Djabarouti S; Bel JC; Guyot R; Saux MC; Allaouchiche B
    J Antimicrob Chemother; 2004 Mar; 53(3):533-5. PubMed ID: 14963066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver tissue concentrations of levofloxacin after single intravenous administration of 500 mg for antibiotic prophylaxis in liver surgery.
    Weinrich M; Scheingraber S; Stremovskaia T; Schilling MK; Kees F; Pistorius GA
    Int J Antimicrob Agents; 2006 Sep; 28(3):221-5. PubMed ID: 16904875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.